Hillsdale Investment Management Inc. Veracyte, Inc. Transaction History

Hillsdale Investment Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 12, 2020	SELL	$20.78 - $29.99 $725,222 - $1.05 Million	-34,900 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$23.87 - $30.93 $23,870 - $30,930	-1,000 Reduced 2.79%	34,900 $838,000
Q2 2019 Aug 02, 2019	BUY	$22.1 - $28.56 $145,860 - $188,496	6,600 Added 22.53%	35,900 $1.02 Million
Q1 2019 May 13, 2019	BUY	$12.0 - $25.76 $351,600 - $754,768	29,300 New	29,300 $733,000

254

82.1M

42.3K

18.2K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.42B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Hillsdale Investment Management Inc., based on Form 13F filings with the SEC.

Stay updated on Hillsdale Investment Management Inc. with notifications on news.